Logo image of VRA

VERA BRADLEY INC (VRA) Stock Fundamental Analysis

NASDAQ:VRA - Nasdaq - US92335C1062 - Common Stock - Currency: USD

2.08  +0.03 (+1.46%)

Fundamental Rating

2

VRA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. The financial health of VRA is average, but there are quite some concerns on its profitability. VRA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

VRA had negative earnings in the past year.
VRA had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VRA reported negative net income in multiple years.
In multiple years VRA reported negative operating cash flow during the last 5 years.
VRA Yearly Net Income VS EBIT VS OCF VS FCFVRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

VRA has a worse Return On Assets (-32.67%) than 86.00% of its industry peers.
With a Return On Equity value of -59.94%, VRA is not doing good in the industry: 76.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -32.67%
ROE -59.94%
ROIC N/A
ROA(3y)-10.99%
ROA(5y)-5.57%
ROE(3y)-18.49%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
VRA Yearly ROA, ROE, ROICVRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

With a Gross Margin value of 48.89%, VRA perfoms like the industry average, outperforming 52.00% of the companies in the same industry.
In the last couple of years the Gross Margin of VRA has declined.
The Profit Margin and Operating Margin are not available for VRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.67%
VRA Yearly Profit, Operating, Gross MarginsVRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

6

2. Health

2.1 Basic Checks

VRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
VRA has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, VRA has less shares outstanding
VRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VRA Yearly Shares OutstandingVRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
VRA Yearly Total Debt VS Total AssetsVRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 2.40 indicates that VRA is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.40, VRA is doing worse than 64.00% of the companies in the same industry.
There is no outstanding debt for VRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.4
ROIC/WACCN/A
WACC9.1%
VRA Yearly LT Debt VS Equity VS FCFVRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

VRA has a Current Ratio of 2.28. This indicates that VRA is financially healthy and has no problem in meeting its short term obligations.
VRA's Current ratio of 2.28 is fine compared to the rest of the industry. VRA outperforms 62.00% of its industry peers.
A Quick Ratio of 0.61 indicates that VRA may have some problems paying its short term obligations.
VRA has a worse Quick ratio (0.61) than 84.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 0.61
VRA Yearly Current Assets VS Current LiabilitesVRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for VRA have decreased strongly by -290.48% in the last year.
The Revenue for VRA has decreased by -24.95% in the past year. This is quite bad
Measured over the past years, VRA shows a decrease in Revenue. The Revenue has been decreasing by -5.56% on average per year.
EPS 1Y (TTM)-290.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.43%
Revenue 1Y (TTM)-24.95%
Revenue growth 3Y-11.71%
Revenue growth 5Y-5.56%
Sales Q2Q%-35.92%

3.2 Future

Based on estimates for the next years, VRA will show a very strong growth in Earnings Per Share. The EPS will grow by 45.22% on average per year.
Based on estimates for the next years, VRA will show a very negative growth in Revenue. The Revenue will decrease by -13.28% on average per year.
EPS Next Y2.11%
EPS Next 2Y45.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-27.55%
Revenue Next 2Y-13.28%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VRA Yearly Revenue VS EstimatesVRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
VRA Yearly EPS VS EstimatesVRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VRA. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 29.42, VRA can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VRA indicates a slightly more expensive valuation: VRA is more expensive than 66.00% of the companies listed in the same industry.
VRA is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 36.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 29.42
VRA Price Earnings VS Forward Price EarningsVRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VRA Per share dataVRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VRA does not grow enough to justify the current Price/Earnings ratio.
VRA's earnings are expected to grow with 45.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.22%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VRA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VERA BRADLEY INC

NASDAQ:VRA (7/17/2025, 8:00:02 PM)

2.08

+0.03 (+1.46%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)06-11 2025-06-11/bmo
Earnings (Next)09-09 2025-09-09
Inst Owners70.63%
Inst Owner Change0%
Ins Owners7.78%
Ins Owner Change-13.74%
Market Cap58.09M
Analysts80
Price Target4.08 (96.15%)
Short Float %12.77%
Short Ratio6.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-377%
Min EPS beat(2)-556.97%
Max EPS beat(2)-197.03%
EPS beat(4)0
Avg EPS beat(4)-330.38%
Min EPS beat(4)-556.97%
Max EPS beat(4)-21.99%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.34%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-4.37%
Revenue beat(4)0
Avg Revenue beat(4)-10.23%
Min Revenue beat(4)-19.17%
Max Revenue beat(4)-4.37%
Revenue beat(8)0
Avg Revenue beat(8)-8.28%
Revenue beat(12)2
Avg Revenue beat(12)-5.52%
Revenue beat(16)2
Avg Revenue beat(16)-5.68%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-3100%
EPS NY rev (1m)-320%
EPS NY rev (3m)-320%
Revenue NQ rev (1m)-3.48%
Revenue NQ rev (3m)-4.14%
Revenue NY rev (1m)-1.96%
Revenue NY rev (3m)-1.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 29.42
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 0.4
P/tB 0.4
EV/EBITDA N/A
EPS(TTM)-0.8
EYN/A
EPS(NY)0.07
Fwd EY3.4%
FCF(TTM)-1.02
FCFYN/A
OCF(TTM)-0.61
OCFYN/A
SpS12.28
BVpS5.23
TBVpS5.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.67%
ROE -59.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.89%
FCFM N/A
ROA(3y)-10.99%
ROA(5y)-5.57%
ROE(3y)-18.49%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.67%
F-Score4
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 37.37%
Cap/Sales 3.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.28
Quick Ratio 0.61
Altman-Z 2.4
F-Score4
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)37.76%
Cap/Depr(5y)36.59%
Cap/Sales(3y)1.74%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-290.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.43%
EPS Next Y2.11%
EPS Next 2Y45.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.95%
Revenue growth 3Y-11.71%
Revenue growth 5Y-5.56%
Sales Q2Q%-35.92%
Revenue Next Year-27.55%
Revenue Next 2Y-13.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-418.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.75%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-54.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.19%
OCF growth 3YN/A
OCF growth 5YN/A